Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors

Objective: to study the sensitivity of gastrointestinal stromal tumors (GISTs) to the topoisomerases type II inhibitors and ability of imatinib to enhance GISTs sensitivity to the chemotherapeutic drugs indicated above.Subjects and Methods. We studied the sensitivity of gastrointestinal stromal tumo...

Full description

Bibliographic Details
Main Authors: S. V. Boichuk, A. R. Galembikova, B. R. Ramazanov, A. Duensing
Format: Article
Language:Russian
Published: ABV-press 2015-06-01
Series:Успехи молекулярной онкологии
Subjects:
Online Access:https://umo.abvpress.ru/jour/article/view/7
_version_ 1797759378875482112
author S. V. Boichuk
A. R. Galembikova
B. R. Ramazanov
A. Duensing
author_facet S. V. Boichuk
A. R. Galembikova
B. R. Ramazanov
A. Duensing
author_sort S. V. Boichuk
collection DOAJ
description Objective: to study the sensitivity of gastrointestinal stromal tumors (GISTs) to the topoisomerases type II inhibitors and ability of imatinib to enhance GISTs sensitivity to the chemotherapeutic drugs indicated above.Subjects and Methods. We studied the sensitivity of gastrointestinal stromal tumors (GISTs) to the topoisomerases II inhibitors and ability of imatinib to enhance GISTs sensitivity to these chemotherapeutic agents. The expression of DNA damage and repair (DDR) markers was examined by western-blotting. Cleaved forms of poly (ADP-rybose) polymerase and caspase-3 were served as an apoptotic markers measured by western blotting. Amount of apoptotic cells was counted by flow cytometry analysis by using a propidium iodide DNA staining procedure and counting the numbers of hypodiploid cells.Results. We observed the sensitivity of GISTs to topoisomerase II inhibitors – doxorubicine and etoposide inducing DNA double-strand breaks and apoptotic cell death. Imatinib enhances GISTs sensitivity to topoisomerase II inhibitors. This might be due to reduced ability of GISTs to repair DNA damage by homologous recombination. Imatinib-induced reduction of Rad51 recombinase might be due to increased proteasome-dependent degradation.Conclusion. GIST cells are sensitive to topoisomerase II inhibitors (etoposide and doxorubicin) in vitro. Imatinib enhances GISTs sensitivity to the chemotherapeutic agents indicated above.
first_indexed 2024-03-12T18:43:35Z
format Article
id doaj.art-38a4a30fa0504f2c97c29df7657fb45c
institution Directory Open Access Journal
issn 2313-805X
2413-3787
language Russian
last_indexed 2024-03-12T18:43:35Z
publishDate 2015-06-01
publisher ABV-press
record_format Article
series Успехи молекулярной онкологии
spelling doaj.art-38a4a30fa0504f2c97c29df7657fb45c2023-08-02T07:48:04ZrusABV-pressУспехи молекулярной онкологии2313-805X2413-37872015-06-012107608110.17650/2313-805X.2015.2.1.076-0817Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitorsS. V. Boichuk0A. R. Galembikova1B. R. Ramazanov2A. Duensing3ГБОУ ВПО «Казанский государственный медицинский университет» Минздрава России; Раковый центр Университета г. ПиттсбургаГБОУ ВПО «Казанский государственный медицинский университет» Минздрава РоссииГБОУ ВПО «Казанский государственный медицинский университет» Минздрава РоссииРаковый центр Университета г. ПиттсбургаObjective: to study the sensitivity of gastrointestinal stromal tumors (GISTs) to the topoisomerases type II inhibitors and ability of imatinib to enhance GISTs sensitivity to the chemotherapeutic drugs indicated above.Subjects and Methods. We studied the sensitivity of gastrointestinal stromal tumors (GISTs) to the topoisomerases II inhibitors and ability of imatinib to enhance GISTs sensitivity to these chemotherapeutic agents. The expression of DNA damage and repair (DDR) markers was examined by western-blotting. Cleaved forms of poly (ADP-rybose) polymerase and caspase-3 were served as an apoptotic markers measured by western blotting. Amount of apoptotic cells was counted by flow cytometry analysis by using a propidium iodide DNA staining procedure and counting the numbers of hypodiploid cells.Results. We observed the sensitivity of GISTs to topoisomerase II inhibitors – doxorubicine and etoposide inducing DNA double-strand breaks and apoptotic cell death. Imatinib enhances GISTs sensitivity to topoisomerase II inhibitors. This might be due to reduced ability of GISTs to repair DNA damage by homologous recombination. Imatinib-induced reduction of Rad51 recombinase might be due to increased proteasome-dependent degradation.Conclusion. GIST cells are sensitive to topoisomerase II inhibitors (etoposide and doxorubicin) in vitro. Imatinib enhances GISTs sensitivity to the chemotherapeutic agents indicated above.https://umo.abvpress.ru/jour/article/view/7гастроинтестинальные стромальные опухолииматинибхимиопрепаратыапоптозповреждение и репарация днкрекомбиназа rad51
spellingShingle S. V. Boichuk
A. R. Galembikova
B. R. Ramazanov
A. Duensing
Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
Успехи молекулярной онкологии
гастроинтестинальные стромальные опухоли
иматиниб
химиопрепараты
апоптоз
повреждение и репарация днк
рекомбиназа rad51
title Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
title_full Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
title_fullStr Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
title_full_unstemmed Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
title_short Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
title_sort imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase ii inhibitors
topic гастроинтестинальные стромальные опухоли
иматиниб
химиопрепараты
апоптоз
повреждение и репарация днк
рекомбиназа rad51
url https://umo.abvpress.ru/jour/article/view/7
work_keys_str_mv AT svboichuk imatinibenchancesthesensitivityofgastrointestinalstromaltumorstotopoisomeraseiiinhibitors
AT argalembikova imatinibenchancesthesensitivityofgastrointestinalstromaltumorstotopoisomeraseiiinhibitors
AT brramazanov imatinibenchancesthesensitivityofgastrointestinalstromaltumorstotopoisomeraseiiinhibitors
AT aduensing imatinibenchancesthesensitivityofgastrointestinalstromaltumorstotopoisomeraseiiinhibitors